|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 800 10th STREET, NW |
Address2 | Two City Center, Suite 400 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-4956 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 2571-12
|
||||||||
|
6. House ID# 306350000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Stacey Hughes |
Date | 4/20/2026 3:58:39 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2761 / H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act , all provisions; H.R. 5142, The Home Health Stabilization Act, all provisions; H.R. 4313 / S. 2237, Hospital Inpatient Services Modernization Act of 2025, all provisions; S. 1261 / H.R. 4206, CONNECT for Health Act of 2025, all provisions; H.R. 1805, Assistance for Rural Community Hospitals (ARCH) Act, all provisions; H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions; S. 335, Rural Hospital Support Act, all provisions; S.1816 / H.R.3514 , Improving Seniors Timely Access to Care Act, all provisions; S. 502 / H.R. 6240 , Rural Hospital Closure Relief Act, all provisions; S. 2439 / H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions; H.R. 4002, Patient Access to Higher Quality Health Care Act, all provisions; DRAFT, Blood Pressure MATTERS Act, all provisions; H.R. 5454/S. 2879, the Medicare Advantage Prompt Pay Act, all provisions; DRAFT, Rural Teaching Hospital Relief, all provisions; S. 2793, Ensuring Access to Essential Providers, all provisions; H.R. 10136, Promoting Fairness for Medicare Providers Act, all provisions; H.R. 7409, Defend Rural Health Act, all provisions; H.R. 7830, Women Expansion of Learning and Labor Safety (WELLS) Act, all provisions; Centers for Medicare and Medicaid Services (CMS), Issues pertaining completing the CMS Outpatient Prospective Payment System Drug Acquisition Cost Survey; Centers for Medicare and Medicaid Services (CMS), Issues pertaining to written guidance on acceptable signage and other materials that hospitals can use in their emergency departments to discourage violent behavior; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the proposed rule on the Increasing Organ Transplant Access Model; Centers for Medicare and Medicaid Services (CMS), Comments pertaining to proposed rule on the Global Benchmark for Efficient Drug Pricing model; The Medicare Payment Advisory Commission (MedPAC), Issues related to proposed payment updates and Medicare Advantage program; Centers for Medicare and Medicaid Services (CMS), Medicare Program Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Issue pertaining to proposed rule for policy and technical changes to the Medicare Advantage and Part D programs in contract year 2027; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the upcoming rulemaking implementing requirements related to hospital off-campus provider-based departments; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the Comprehensive Regulations To Uncover Suspicious Healthcare (CRUSH), which includes efforts to combat fraud waste and abuse in federal health care programs; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the proposed rulemaking on potential options to foster a more resilient supply chain for American-made personal protective equipment and essential medicines; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to expanding the use of Medicare Conditions of Participation (CoP); Centers for Medicare and Medicaid Services (CMS), Issues pertaining to the proposed Notice of Benefit and Payment Parameters for 2027; Centers for Medicare and Medicaid Services (CMS), Issues pertaining to implementation of unique national provider (NPI) for hospital off-campus provider-based departments as outlined in Consolidated Appropriations Act of 2026; Medicaid Program, Issues pertaining to Medicaid program and how states finance programs, reimburse providers, and determine beneficiary eligibility, and implementation of H.R. 1 provisions related to state directed payments and provider taxes; Site Neutral Payments, Issues related to site neutral payment cuts; Rural Hospitals, Issues pertaining to the sustainability of MDHS, CAHs, SCHs, REH's, implementation of Rural Health Transformation Program, rural reclassification policy; Physician Payments, Issues pertaining to alternative payment models, mental health of workforce, physician reimbursement cuts, Medicare Access & CHIP Reauthorization (MACRA) Reforms; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay and cost-based reimbursement for critical access hospitals under Medicare Advantage, Wasteful and Inappropriate Services Reduction (WISeR) model, transparency in plan denial signatures, inappropriate downcoding; Provider Reimbursements, Issues related to provider reimbursement, site neutral payment cuts, Medicare/Medicaid program funding, facility fees, DSH cuts, oversight; Expiring Health Care Provisions, Issues pertaining to Telehealth, Hospital at Home, MDH/LVA, Medicaid DSH Program; Post Acute Care, Issues pertaining to expanding and protecting patients access to services provided by long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, and home health agencies; Rural Community Hospital Demonstration Project, Issues related to ending the Rural Community Hospital Demonstration Project.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Megan |
Cundari |
|
|
|
Aimee Hartlage |
Kuhlman |
|
|
|
Priscilla |
Ross |
|
|
|
Akin |
Demehin |
|
|
|
Joanna |
Kim |
|
|
|
Roslyne |
Schulman |
|
|
|
Ashley |
Thompson |
|
|
|
Kristina |
Weger |
|
|
|
Travis |
Robey |
|
|
|
Lisa Kidder |
Hrobsky |
|
|
|
Molly |
Smith |
|
|
|
Aaron |
Wesolowski |
|
|
|
Ariel |
Levin |
|
|
|
Benjamin |
Finder |
|
|
|
Stacey |
Hughes |
|
|
|
Shannon |
Wu |
|
|
|
Jason |
Kleinman |
|
|
|
Terrence |
Cunningham |
|
|
|
Rachel |
Jenkins |
|
|
|
Devin |
Gerzof |
|
|
|
Jonathan |
Gold |
|
|
|
Jennifer |
Holloman |
|
|
|
Kristin |
Schwartz |
|
|
|
Caitlin |
Gillooley |
|
|
|
Bharath |
Krishnamurthy |
|
|
|
Adrienne |
Thomas |
|
|
|
Eduardo |
Sacasa |
|
Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019. |
|
Thifeen |
Deen |
|
Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 4581 / S.2372, 340B PATIENTS Act, all provisions; H.R. 3178 / S. 1600, The Save Healthcare Workers Act, all provisions; H.R. 929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; S. 1874, Title VIII Nursing Workforce Reauthorization Act, all provisions; S. 2169, Rural, Hospital Cybersecurity Enhancement Act, all provisions; H.R. 5283 / S. 2759, Healthcare Workforce Resilience Act, all provisions; S. 3315, Health Care Cybersecurity and Resiliency Act of 2025, all provisions; H.R. 5256, 340B Access Act, all provisions; S. 1929, SEPSIS Act, all provisions; S. 2355 / H.R. 5582, Patients Deserve Price Tags Act, all provisions; H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; S. 3435 / H.R. 6607, The Future Advancement of Academic Nursing, all provisions; H.R. 5428, Medical Student Education Authorization Act of 2025, all provisions; H.R. 7920 / S. 4085, Take Back Our Hospitals Act, all provisions; S. 4208, A bill to establish a demonstration program to provide payments on eligible loans for individuals who are eligible for the National Health Service Corps Loan Repayment Program, all provisions; DRAFT, Conrad 30 Enhancement Bill, all provisions; DRAFT, Rural Maternity Bill, all provisions; S.3788, Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act, all provisions; S.3822, Break Up Big Medicine Act, all provisions; H.R.7727, Sustaining Rural Healthcare Act, all provisions; DRAFT, Preserving Patient Access Act, all provisions; H.R. 5629, Medications for the Treatment of Opioid Use Disorder (OUD), all provisions; S. 4141, Rural Hospital Revitalization Act of 2026, all provisions; H.R. 7478, Patient Debt Relief Act, all provisions; Federal Trade Commission, Issue pertaining to the remarks at the forge Mason Law Review 29th Annual Antitrust Symposium; Department of Health & Human Services / Office of the National Coordinator for Health IT, Issues pertaining to Health Data, Technology and Interoperability; Health Resources and Services Administration (HRSA), Comments pertaining to Eli Lilly and Company policy and impact to 340B hospitals; Health Resources and Services Administration (HRSA), Comments pertaining to Novo Nordisk policy and impact to 340B hospitals; Health Resources and Services Administration (HRSA), Comments pertaining to the request for information on a new 340B rebate model program; Department of Health & Human Services / Office of the National Coordinator for Health IT, Issues pertaining to diagnostic imaging interoperability; U.S. Department of Education, Issues pertaining to proposed rule implementing borrowing limits for federal student loans and impact on health care workforce; U.S. Department of Health & Human Services (HHS), Issues pertaining to accelerating the adoption and use of AI as part of clinical care; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program, including 340B Rebate Model Pilot Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP); Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Issues pertaining to workforce development programs, supporting health care workforce and physician shortages, definitions of professional degree programs and borrowing limits, loan repayment programs for providers in rural and underserved areas, Graduate Medical Education program; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay, white-bagging and brown-bagging policies; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, strengthen health care cybersecurity, cybersecurity workforce, and securing drug supply chains, hospital preparedness program, PAHPA reauthorization, outstanding FEMA COVID payments to hospitals; Price Transparency, Issues related to hospital price transparency; Affordability, Issues pertaining to the cost of health care; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce; AI in Healthcare, Issues pertaining to the use of AI in healthcare.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC), Education - Dept of, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Megan |
Cundari |
|
|
|
Aimee Hartlage |
Kuhlman |
|
|
|
Priscilla |
Ross |
|
|
|
Akin |
Demehin |
|
|
|
Joanna |
Kim |
|
|
|
Roslyne |
Schulman |
|
|
|
Ashley |
Thompson |
|
|
|
Kristina |
Weger |
|
|
|
Travis |
Robey |
|
|
|
Lisa Kidder |
Hrobsky |
|
|
|
Molly |
Smith |
|
|
|
Aaron |
Wesolowski |
|
|
|
Ariel |
Levin |
|
|
|
Benjamin |
Finder |
|
|
|
Stacey |
Hughes |
|
|
|
Shannon |
Wu |
|
|
|
Jason |
Kleinman |
|
|
|
Terrence |
Cunningham |
|
|
|
Rachel |
Jenkins |
|
|
|
Devin |
Gerzof |
|
|
|
Jonathan |
Gold |
|
|
|
Jennifer |
Holloman |
|
|
|
Kristin |
Schwartz |
|
|
|
Caitlin |
Gillooley |
|
|
|
Bharath |
Krishnamurthy |
|
|
|
Adrienne |
Thomas |
|
|
|
Eduardo |
Sacasa |
|
Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019. |
|
Thifeen |
Deen |
|
Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 7148, The Consolidated Appropriations Act, 2026, Division B - Title II (Dept. of Health & Human Services), Division J, Health Care Extenders.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Megan |
Cundari |
|
|
|
Aimee Hartlage |
Kuhlman |
|
|
|
Priscilla |
Ross |
|
|
|
Akin |
Demehin |
|
|
|
Joanna |
Kim |
|
|
|
Roslyne |
Schulman |
|
|
|
Ashley |
Thompson |
|
|
|
Kristina |
Weger |
|
|
|
Travis |
Robey |
|
|
|
Lisa Kidder |
Hrobsky |
|
|
|
Molly |
Smith |
|
|
|
Aaron |
Wesolowski |
|
|
|
Ariel |
Levin |
|
|
|
Benjamin |
Finder |
|
|
|
Stacey |
Hughes |
|
|
|
Shannon |
Wu |
|
|
|
Jason |
Kleinman |
|
|
|
Terrence |
Cunningham |
|
|
|
Rachel |
Jenkins |
|
|
|
Devin |
Gerzof |
|
|
|
Jonathan |
Gold |
|
|
|
Jennifer |
Holloman |
|
|
|
Kristin |
Schwartz |
|
|
|
Caitlin |
Gillooley |
|
|
|
Bharath |
Krishnamurthy |
|
|
|
Adrienne |
Thomas |
|
|
|
Eduardo |
Sacasa |
|
Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019. |
|
Thifeen |
Deen |
|
Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Tariffs, Issues pertaining to impact of tariffs on hospitals and health systems.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Megan |
Cundari |
|
|
|
Aimee Hartlage |
Kuhlman |
|
|
|
Priscilla |
Ross |
|
|
|
Akin |
Demehin |
|
|
|
Joanna |
Kim |
|
|
|
Roslyne |
Schuman |
|
|
|
Ashley |
Thompson |
|
|
|
Kristina |
Weger |
|
|
|
Travis |
Robey |
|
|
|
Lisa Kidder |
Hrobsky |
|
|
|
Molly |
Smith |
|
|
|
Aaron |
Wesolowski |
|
|
|
Ariel |
Levin |
|
|
|
Benjamin |
Finder |
|
|
|
Stacey |
Hughes |
|
|
|
Shannon |
Wu |
|
|
|
Jason |
Kleinman |
|
|
|
Terrence |
Cunningham |
|
|
|
Rachel |
Jenkins |
|
|
|
Devin |
Gerzof |
|
|
|
Jonathan |
Gold |
|
|
|
Jennifer |
Holloman |
|
|
|
Kristin |
Schwartz |
|
|
|
Caitlin |
Gillooley |
|
|
|
Bharath |
Krishnamurthy |
|
|
|
Adrienne |
Thomas |
|
|
|
Eduardo |
Sacasa |
|
Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019. |
|
Thifeen |
Deen |
|
Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; H.R. 4393, Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act of 2025, all provisions; Immigration, Issues pertaining to H1-B Visa Program and other immigration changes, impact to health care workforce.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Homeland Security - Dept of (DHS), White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Megan |
Cundari |
|
|
|
Aimee Hartlage |
Kuhlman |
|
|
|
Priscilla |
Ross |
|
|
|
Akin |
Demehin |
|
|
|
Joanna |
Kim |
|
|
|
Roslyne |
Schuman |
|
|
|
Ashley |
Thompson |
|
|
|
Kristina |
Weger |
|
|
|
Travis |
Robey |
|
|
|
Lisa Kidder |
Hrobsky |
|
|
|
Molly |
Smith |
|
|
|
Aaron |
Wesolowski |
|
|
|
Ariel |
Levin |
|
|
|
Benjamine |
Finder |
|
|
|
Stacey |
Hughes |
|
|
|
Shannon |
Wu |
|
|
|
Jason |
Kleinman |
|
|
|
Terrence |
Cunningham |
|
|
|
Rachel |
Jenkins |
|
|
|
Devin |
Gerzof |
|
|
|
Jonathan |
Gold |
|
|
|
Jennifer |
Holloman |
|
|
|
Kristin |
Schwartz |
|
|
|
Caitlin |
Gillooley |
|
|
|
Bharath |
Krishnamurthy |
|
|
|
Adrienne |
Thomas |
|
|
|
Eduardo |
Sacasa |
|
Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019. |
|
Thifeen |
Deen |
|
Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |